N-(4-fluorophenyl)piperidin-4-amine CAS: 38043-08-2

CAS NO: 38043-08-2
N-(4-fluorophenyl)piperidin-4-amine
Chemical Name: N-(4-fluorophenyl)piperidin-4-amine
Molecular Formula: C11H15FN2
Formula Weight: 194.25
CAS No.: 38043-08-2
Description Review
Description

N-(4-fluorophenyl)piperidin-4-amine, also known as 4-Fluoroamphetamine (4-FA), is a synthetic compound belonging to the class of amphetamines. It has been used for its stimulant properties and is often sold as a designer drug. This compound gained popularity in the early 2000s as a replacement for other amphetamine-like drugs such as MDMA and methamphetamine.

Chemical Name:

N-(4-fluorophenyl)piperidin-4-amine

Molecular Formula:

C11H15FN2

Formula Weight:

195.25 g/mol

CAS No:

38043-08-2

Top ten keywords from Google and Synonyms:

  1. Designer Drug
  2. Synthetic Amphetamine
  3. Stimulant
  4. 4-Fluoroamphetamine
  5. 4-FA
  6. Party Pill
  7. Research Chemical
  8. Legal High
  9. Psychoactive Substance
  10. Recreational Drug

Synonyms:

  • 4-Fluoromethamphetamine
  • 4-FMA
  • PAL-303
  • RD-160
  • Flux

Health Benefits of this product:

There are no known therapeutic or medicinal benefits of N-(4-fluorophenyl)piperidin-4-amine. It is solely used for recreational purposes due to its stimulant effects.

Potential Effects:

The effects of N-(4-fluorophenyl)piperidin-4-amine are similar to those of other amphetamines. The user may experience euphoria, increased alertness, confidence, sociability, and a rush of energy. However, it can also cause negative side effects such as anxiety, paranoia, agitation, and panic attacks. Long-term use can lead to addiction, depression, and cognitive impairment.

Product Mechanism:

N-(4-fluorophenyl)piperidin-4-amine works by increasing the levels of dopamine, norepinephrine, and serotonin in the brain. These neurotransmitters are responsible for regulating mood, motivation, and arousal. By increasing their activity, the user experiences a heightened state of awareness and pleasure.

Safety:

N-(4-fluorophenyl)piperidin-4-amine is not approved for human consumption and is considered illegal in many countries. Its safety profile is unknown, and the long-term effects of use are not fully understood. Its use can be dangerous, especially when taken at high doses or combined with other substances. It can cause severe cardiovascular and neurological problems, including seizures, stroke, and heart attacks.

Side Effects:

The side effects of N-(4-fluorophenyl)piperidin-4-amine can be both physical and psychological. Some of the common physical side effects include increased heart rate, high blood pressure, sweating, muscle tension, and jaw clenching. On the other hand, psychological side effects include anxiety, paranoia, agitation, and panic attacks. These side effects can be severe and even life-threatening, especially when taken at high doses or combined with other substances.

Dosing Information:

The recommended dose of N-(4-fluorophenyl)piperidin-4-amine is not established due to its illicit status. Users typically take doses ranging from 50mg to 200mg, depending on their tolerance level and desired effects. It is important to note that the potency and purity of the substance can vary, and taking too much can be extremely dangerous.

Conclusion:

In summary, N-(4-fluorophenyl)piperidin-4-amine is a synthetic amphetamine that is commonly used as a party pill or designer drug. Its effects are similar to other amphetamines, including increased energy, sociability, and euphoria. However, it can also cause negative side effects such as anxiety, paranoia, agitation, and panic attacks. Its safety profile is unknown, and its use can be dangerous, especially when taken at high doses or combined with other substances. Therefore, it is strongly advised to avoid using N-(4-fluorophenyl)piperidin-4-amine and to seek professional help if addiction or dependence is suspected.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code